| 臺大學術典藏 |
2018-09-10T08:12:34Z |
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections
|
Cheng, C.-Y. and Sheng, W.-H. and Wang, J.-T. and Chen, Y.-C. and Chang, S.-C.; WANG-HUEI SHENG; SHAN-CHWEN CHANG; YEE-CHUN CHEN; JANN-TAY WANG |
| 臺大學術典藏 |
2021-02-26T02:00:09Z |
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections
|
Cheng C.-Y.;Wang-Huei Sheng;Wang J.-T.;Chen Y.-C.;Chang S.-C.; Cheng C.-Y.; WANG-HUEI SHENG; Wang J.-T.; Chen Y.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-05-06T01:52:31Z |
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections
|
Cheng C.-Y.; Sheng W.-H.; Wang J.-T.; YEE-CHUN CHEN; Chang S.-C. |
| 臺大學術典藏 |
2020-09-29T01:47:58Z |
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections
|
Chang S.-C.; YEE-CHUN CHEN; Wang J.-T.; Sheng W.-H.; Cheng C.-Y. |
| 臺大學術典藏 |
2019-02-13T05:00:44Z |
Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: week 52 results from SPIRIT-P2
|
TSEN-FANG TSAI; TSEN-FANG TSAI |
| 臺大學術典藏 |
2018 |
Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: Week 52 results from SPIRIT-P2
|
Genovese M.C.;Combe B.;Kremer J.M.;Tsen-Fang Tsai;Behrens F.;Adams D.H.;Lee C.;Kerr L.;Nash P.; Genovese M.C.; Combe B.; Kremer J.M.; TSEN-FANG TSAI; Behrens F.; Adams D.H.; Lee C.; Kerr L.; Nash P. |
| 臺大學術典藏 |
2022-03-22T08:28:50Z |
Safety and efficacy of kartigen? in treating cartilage defects: A randomized, controlled, phase i trial
|
Liu Y.-L;Yen C.-C;Liu T.-S.T;Chang C.-H;Shih T.T.-F;Wang J.-H;Yang M.-C;Lin F.-H;Liu H.-C.; Liu Y.-L; Yen C.-C; Liu T.-S.T; Chang C.-H; Shih T.T.-F; Wang J.-H; Yang M.-C; Lin F.-H; Liu H.-C.; FENG-HUEI LIN |
| 臺大學術典藏 |
2022-03-22T08:31:52Z |
Safety and efficacy of kartigen? in treating cartilage defects: A randomized, controlled, phase i trial
|
Liu Y.-L;Yen C.-C;Liu T.-S.T;Chang C.-H;Shih T.T.-F;Wang J.-H;Yang M.-C;Lin F.-H;Liu H.-C.; Liu Y.-L; Yen C.-C; Liu T.-S.T; Chang C.-H; Shih T.T.-F; Wang J.-H; Yang M.-C; Lin F.-H; Liu H.-C.; FENG-HUEI LIN |
| 臺大學術典藏 |
2022-03-22T08:31:54Z |
Safety and efficacy of kartigen? in treating cartilage defects: A randomized, controlled, phase i trial
|
Liu Y.-L;Yen C.-C;Liu T.-S.T;Chang C.-H;Shih T.T.-F;Wang J.-H;Yang M.-C;Lin F.-H;Liu H.-C.; Liu Y.-L; Yen C.-C; Liu T.-S.T; Chang C.-H; Shih T.T.-F; Wang J.-H; Yang M.-C; Lin F.-H; Liu H.-C.; FENG-HUEI LIN |
| 臺大學術典藏 |
2021-12-16T03:30:15Z |
Safety and Efficacy of Kartigen® in Treating Cartilage Defects: A Randomized, Controlled, Phase I Trial
|
Liu, Yen-Liang; Yen, Chun-Che; Liu, Tzu-Shang Thomas; Chang, Chih-Hung; TIFFANY TING-FANG SHIH; Wang, Jyh-Horng; Yang, Ming-Chia; Lin, Feng-Huei; Liu, Hwa-Chang |
